Skip to main content

Table 1 Demographics, illness severity, and haemodynamic and echocardiographic findings

From: Prevalence and prognostic value of various types of right ventricular dysfunction in mechanically ventilated septic patients

Categories

All patients (n = 215)

Normal (n = 101)

RVF only (n = 38)

RVSD only (n = 44)

RVF/RVSD (n = 32)

p value

Age (year)

65 (50, 73)

64 (50, 73)

65 (47, 74)

64 (57, 75)

65 (51, 74)

0.774

Sex (male, %)

134 (62.3%)

61 (60.4%)

24 63.2%)

28 (63.6%)

21 (65.6%)

0.104

APACHE II

20 (15, 26)

19 (13, 26)

19 (14, 24)

22 (17, 27)

24 (18, 30)

0.043b, c

SOFA

12 (9, 14)

11 (8, 13)

12 (8, 13)

13 (10, 15)

14 (11, 17)

0.007b, c, e

HR (bpm)

94 ± 20

93 ± 16

88 ± 21

98 ± 22

97 ± 22

0.109

MAP (mmHg)

76 (66, 82)

75 (66, 85)

77 (71, 84)

76 (66, 83)

72 (68, 76)

0.268

CVP (mmHg)

9 (7, 11)

8 (6, 10)

9 (8, 11)

8 (7, 10)

10 (8, 12)

 < 0.001a, c, f

PEEP (cmH2O)

5 (5, 8)

5 (5, 6)

5 (5, 7)

6 (5, 8)

6 (5, 10)

0.001b, c, e

Pplat (cmH2O)

18 (16, 22)

18 (16, 21)

19 (15, 22)

18 (16, 20)

20 (18, 23)

0.097

*Fluid before echo (ml)

3764 (3206, 4589)

3722 (2677, 4704)

3701 (3193, 4471)

3773 (3326, 4598)

3884 (2945, 4804)

0.992

R/LVEDA

0.55 (0.45, 0.65)

0.49 (0.43, 0.55)

0.67 (0.63, 0.71)

0.45 (0.39, 0.53)

0.68 (0.63, 0.72)

 < 0.001a, c, d, f

TAPSE (mm)

19.0 ± 5.1

21.8 ± 3.6

21.5 ± 4.0

14.0 ± 2.9

14.0 ± 3.3

 < 0.001b, c, d, e

FAC (%)

46 (38, 52)

49 (44, 55)

48 (41, 55)

34 (29, 47)

32 (29, 44)

 < 0.001b, c, d, e

TR (m/s)

2.4 ± 0.5

2.4 ± 0.3

2.4 ± 0.4

2.4 ± 0.5

2.6 ± 0.5

0.112

LVEF (%)

60 (50, 69)

62 (56, 70)

63 (54, 69)

55 (44, 62)

52 (47, 63)

 < 0.001c, d, e

E/e’

8.5 (6.6, 10.7)

8.0 (6.6, 10.0)

7.8 (6.5, 10.8)

8.9 (6.7, 12.2)

9.8 (5.7, 13.5)

0.060

CI (L/min/m2)

3.4 (2.8, 4.0)

3.6 (3.0, 4.2)

3.4 (2.9, 4.3)

3.1 (2.5, 3.8)

3.1 (2.7, 3.7)

 < 0.001c, d, e

MV duration (hr)

100 (36, 235)

91 (30, 232)

93 (30, 172)

105 (67, 211)

138 (62,282)

0.379

ICU stay (day)

6 (3, 12)

6 (3, 11)

4 (3, 10)

7 (4, 12)

7 (3, 14)

0.086

30-day mortality (n, %)

50 (23.2%)

14 (13.9%)

5 (13.2%)

15 (34.1%)

16 (50%)

 < 0.001b, c

  1. *Fluid administered within 24 h before echo examination
  2. aRVF/RVSD vs. RVSD, p < 0.05; bRVF/RVSD vs. RVF, p < 0.05; cRVF/RVSD vs. Normal, p < 0.05; dRVSD vs. RVF, p < 0.05; eRVSD vs. Normal, p < 0.05; fRVF vs. Normal, p < 0.05
  3. APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, HR heart rate, MAP: mean arterial pressure, CVP central venous pressure, PEEP positive end-expiratory pressure, Pplat plateau pressure, R/LVEDA ratio of right and left end-diastolic area, TAPSE tricuspid annular plane systolic excursion, FAC fractional area change, TR tricuspid regurgitation, LVEF left ventricular ejection fraction, CI cardiac index, MV mechanical ventilation, ICU intensive care unit